StonvexLoading…
StonvexStonvexStonvexCore line items from INSG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $42.10M | $34.34M | $166.19M | $117.79M | $71.90M |
Operating Income | Not available | $-3.57M | $4.32M | $3.01M | $856.00K |
Net Income | Not available | $-4.54M | $838.00K | $369.00K | $-1.06M |
EPS (Diluted) | $0.06 | $0.65 | $-0.18 | $-0.15 | $-0.19 |
Total Assets | Not available | $84.16M | $93.81M | $85.81M | $83.07M |
Total Liabilities | Not available | $109.57M | $97.85M | $93.53M | $93.57M |
Cash & Equivalents | Not available | $19.30M | $24.89M | $14.56M | $13.22M |
Free Cash Flow OCF − CapEx | Not available | $1.58M | $6.53M | $-5.08M | $-8.16M |
Shares Outstanding | Not available | 16.23M | 15.39M | 15.21M | 15.04M |